EAM Investors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-70,115
| Closed | -$2.94M | – | 267 |
|
|
2024
Q1 | $2.94M | Buy |
+70,115
| New | +$2.94M | 0.46% | 122 |
|
|
2023
Q2 | – | Sell |
-46,216
| Closed | -$1.66M | – | 285 |
|
|
2023
Q1 | $1.66M | Sell |
46,216
-9,996
| -18% | -$360K | 0.33% | 148 |
|
|
2022
Q4 | $2.51M | Buy |
+56,212
| New | +$2.51M | 0.52% | 59 |
|
|
2021
Q4 | – | Sell |
-86,399
| Closed | -$4.67M | – | 295 |
|
|
2021
Q3 | $4.67M | Buy |
86,399
+35,866
| +71% | +$1.94M | 0.79% | 7 |
|
|
2021
Q2 | $1.69M | Buy |
+50,533
| New | +$1.69M | 0.26% | 175 |
|
|
2021
Q1 | – | Sell |
-100,259
| Closed | -$1.76M | – | 354 |
|
|
2020
Q4 | $1.76M | Sell |
100,259
-40,870
| -29% | -$716K | 0.29% | 162 |
|
|
2020
Q3 | $2.09M | Buy |
141,129
+72,003
| +104% | +$1.07M | 0.5% | 56 |
|
|
2020
Q2 | $899K | Buy |
+69,126
| New | +$899K | 0.2% | 203 |
|
|
2015
Q1 | – | Sell |
-7,505
| Closed | -$2.06M | – | 339 |
|
|
2014
Q4 | $2.06M | Buy |
+7,505
| New | +$2.06M | 0.29% | 161 |
|
|
2014
Q1 | – | Sell |
-3,776
| Closed | -$1.37M | – | 320 |
|
|
2013
Q4 | $1.37M | Sell |
3,776
-1,523
| -29% | -$553K | 0.25% | 192 |
|
|
2013
Q3 | $2.82M | Sell |
5,299
-9,442
| -64% | -$5.02M | 0.56% | 29 |
|
|
2013
Q2 | $3.45M | Buy |
+14,741
| New | +$3.45M | 0.75% | 11 |
|